Skip to main content

Table 3 Comparing two groups (hematoma expansion group–non hematoma expansion group) in term of qualitative variables

From: Baseline neutrophil–lymphocyte ratio can be associated with hematoma expansion in patients with intracerebral hemorrhage: a retrospective observational study

Variable

Hematoma expansion

Statistical test

Yes (n = 57)

No (n = 164)

Gender

 Male

33 (27.7)

89 (72.3)

P = 0.643

 Female

24 (24.2)

75 (76.8)

Hypertension

 Yes

31 (23.3)

102 (76.69)

P = 0.321

 No

26 (29.5)

62 (70.5)

Diabetes

 Yes

16 (26.6)

44 (73.4)

P = 0.508

 No

41 (25.4)

120 (74.5)

Smoking

 Yes

14 (22.2)

49 (77.8)

P = 0.754

 No

43 (27.2)

115 (72.8)

Hematoma location

 Lobar

28 (28.3)

71 (71.7)

P = 0.866

 Deep

17 (23.9)

54 (76.1)

 Cerebellar

7 (21.2)

26 (78.8)

 Brain stem

5 (27.7)

13 (72.2)

GOS

 Unfavorable outcome

  Death

14 (30.4)

32 (69.6)

P = 0.017

  Vegetative state

7 (28)

18 (72)

  Sever disability

13 (26.5)

36 (73.5)

 Favorable outcome

  Moderate disability

14 (22.9)

47 (77.1)

  Good recovery

9 (22.5)

31 (77.5)

Need for surgery

 Yes

28 (43.7)

36 (56.3)

P = 0.011

 No

29 (18.4)

128 (81.6)

Intera-ventricular hemorrhage

 Yes

12 (25.0)

36 (75.0)

P = 0.210

 No

45 (26.0)

128 (74.0)

Hydrocephalus

 Yes

7 (22.5)

24 (77.5)

P = 0.625

 No

50 (26.3)

140 (73.7)

  1. Bold indicates p < 0.05
  2. GOS Glasgow Outcome Scale